BridgeMD
New treatment option for Chronic Pain
Official title Reboot Pain (tDCS)
ClinicalTrials.gov ID: NCT07411859
What this study is testing
- What it's testing
- This study will examine the effectiveness of tDCS (Transcranial Direct Current Stimulation) in reducing chronic pain when used with Emory Healthcare Veterans Program (EHVP)-ABHP (Accelerated Behavioral Health Program) participants as measured by the Pain, Enjoyment of Life and General Activity Scale (PEG).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89
You may be able to join if
- Male or Female, 18-89 years old
- Treated on site for ABHP
- Willing to self-administer tDCS and complete the measures
- PEG pain intensity of 4 or more for most of the day at least 3 days per week
- Have an established PCP (Primary Care Provider) or pain management provider
You likely can't join if
- Implanted pacemaker
- Seizure Disorder
- Pregnancy, if applicable
- Any new onset of the following:
- Balance Problems
- Difficulty walking
See the full eligibility criteria
- Male or Female, 18-89 years old
- Treated on site for ABHP
- Willing to self-administer tDCS and complete the measures
- PEG pain intensity of 4 or more for most of the day at least 3 days per week
- Have an established PCP (Primary Care Provider) or pain management provider
- Implanted pacemaker
- Seizure Disorder
- Pregnancy, if applicable
- Any new onset of the following:
- Balance Problems
- Difficulty walking
- Bladder incontinence
- Bowel incontinence
- Numbness
- Tingling
- Weakness
- Medical contraindications
- Current use of sodium channel blockers
- Lidocaine (OTC/transdermal delivery is ok)
- Mexiletine
- Amitriptyline; other tricyclic antidepressants
- Anti-epileptic medications: phenytoin, carbamazepine, lamotrigine, oxcarbazepine, rufinamide, lacosamide and eslicarbazepine acetate
- Current use of calcium channel blockers
- Current use of N-Methyl-D-aspartate receptor antagonists
- Ketamine
- Dextromethorphan
- Felbamate
- History of brain surgery
- History of brain tumor
- History of seizure disorder
- History of stroke
- Intracranial metal implantation
- Adults unable to consent
- Individuals who are not yet adults
- Prisoners
- Non-English speaking
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.